Gene editing Cas3-catalyzed DNA destruction plays an important role in genetic editing reactions. Cas3, when complexed with Cascade, can function in targeted genetic insertions and deletions when delivered into cells as proteins with nuclear localization signals. Due to the requirement for Cascade to lock on to the DNA target before Cas3 activation, there is a low rate of off-target effects. Cas3 has been shown to facilitate large regions of genetic deletion, up to 200kb, when expressed in human HEK293 cells. Additionally, the
exon-skipping capabilities of Cas3 show promise for future genetic therapy treatments for conditions such as muscular dystrophy.
CRISPR-mediated adaptive immunity CRISPR-mediated adaptive immunity requires three stages: sequence acquisition, CRISPR RNA biogenesis, and target interference. CRISPR RNA-guided surveillance complexes aid this process in efficiently targeting non-self through the recognition of short motifs. Type IE systems, which use Cas3, use a Cascade as the surveillance complex in this process. Through the binding and bending of Cascade to target DNA, R-loops are formed, and Cas3 is recruited to the complex. ATP enhances Cas3 recruitment to R-loops, and binding enhances Cas3 ATPase activity. The HD-nuclease domain of Cas3 nicks and unidirectionally degrades the target DNA of the displaced strand in the 3' to 5' direction. Cas3-mediated degradation may also recruit
Cas1 and
Cas2, proteins involved in the process of integrating spacers, priming for future foreign immunity. == References ==